ASCO 2016 Multiple Myeloma Update – Days One, Two, And Three
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
3630-Multiple myeloma DVd (daratumumab bortezomib dexamethasone) overview | eviQ
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
SYNOPSIS
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management - Rajkumar - 2020 - American Journal of Hematology - Wiley Online Library
Approved for use in:
Dosing & Treatment Plan for VELCADE® (bortezomib)
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
Cancers | Free Full-Text | Recent Advances in the Treatment of Patients with Multiple Myeloma
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
VAD and similar alternate regimens | Download Table
Treatment of relapsed and refractory multiple myeloma | Haematologica
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion. - Abstract - Europe PMC
Treatment of relapsed and refractory multiple myeloma | Haematologica
JPM | Free Full-Text | Targeted Therapies for Multiple Myeloma
3630-Multiple myeloma DVd (daratumumab bortezomib dexamethasone) overview | eviQ
Frontiers | Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis
Multiple Myeloma - Oncologic Disorders - Pharmacotherapy A Pathophysiologic Approach, 9th Ed.
Multiple myeloma current treatment algorithms | Blood Cancer Journal
Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
Addition of daratumumab to multiple myeloma backbone regimens significantly improves clinical outcomes: a systematic review and meta-analysis of randomised controlled trials | Scientific Reports
Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management - Rajkumar - 2018 - American Journal of Hematology - Wiley Online Library
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study - Yimer - 2019 - British Journal of Haematology - Wiley Online Library
The DVD Regimen After Myeloma Progression
Multiple myeloma current treatment algorithms | Blood Cancer Journal
